University of Missouri to Pay $16.2M To Settle Lawsuits Over “BioJoint” Knee Replacements

As part of a settlement over “BioJoint” knee replacements, the University of Missouri has agreed to pay $16.2 million to 22 plaintiffs who underwent procedures involving use of bones and cartilage from cadavers, which had incredibly high failure rates and sometimes involved surgery by a veterinarian who was not approved to operate on humans.

The BioJoint knee lawsuits were filed between 2018 and 2020, each involving allegations that surgical procedures conducted by orthopedic surgeon Dr. James Stannard and veterinarian Dr. James Cook, both University employees. The plaintiffs indicate the procedures were falsely advertised and had a failure rate of 86%; which was not relayed to patients.

The procedures were marketed for treatment of joint pain and arthritis, but plaintiffs indicate they were not told the BioJoint knee surgery was experimental, and rarely resulted in positive outcomes. In many cases, the patients’ conditions worsened, and they suffered reduced mobility and often needed additional surgeries.

Learn More About

Knee Replacement Lawsuits

Design problems with several types of knee implants have resulted in lawsuits for individuals who experienced painful complications.

Learn More About this Lawsuit See If You Qualify For Compensation

The lawsuits also point to the fact that Cook was not a licensed doctor at the time of the surgeries and was actually a veterinarian, only approved to treat animals. Despite that, documents revealed during the litigation indicated Cook was often listed as a surgeon on patients’ medical records.

Cook is listed as the chief of orthopedic research at the University of Missouri, and as director of operations and research at the Mizzou BioJoint Center. Stannard is the medical director of the Missouri Orthopaedic Institute.

The BioJiont knee settlement was signed last month, and does not include an admission of guilt or liability. However, it will result in a high payout of about $736,000 per plaintiff, on average if divided evenly.

The Mizzou BioJoint Center has been performing the surgeries since at least 2014, and even received a $2 million grant from the U.S. Department of Defense in 2018, in order to research how its surgeries could help soldiers suffering from knee and ankle injuries.

One of the plaintiffs was a former member of the U.S. Army who was referred to the Center by his doctor. However, not only did the surgery not help his knee and back pain, but it worsened, resulting in him needing to use a cane and losing his ability to work.

Media reports indicate it is unclear whether the Mizzou BioJoint Center is still offering the procedure.


"*" indicates required fields

Share Your Comments

I authorize the above comments be posted on this page*

Have Your Comments Reviewed by a Lawyer

Provide additional contact information if you want an attorney to review your comments and contact you about a potential case. This information will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Bard 3DMax Hernia Mesh Lawsuit Set for Trial To Begin in April 2024
Bard 3DMax Hernia Mesh Lawsuit Set for Trial To Begin in April 2024 (Posted today)

With thousands of Bard hernia mesh lawsuits pending in the federal court system, a fourth bellwether trial will be held in the spring, involving allegations that defects with Bard 3DMax caused painful and permanent injuries.

Ozempic Gastroparesis Lawsuit Filed Over Failure To Warn About Permanent Stomach Problems
Ozempic Gastroparesis Lawsuit Filed Over Failure To Warn About Permanent Stomach Problems (Posted 2 days ago)

A South Dakota man has filed one of the first gastroparesis lawsuits against Ozempic manufacturers, alleging that users have not been adequately warned about the risk of severe vomiting and long-term stomach side effects.